8-K
Current Report
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001193125-20-110697
Executive or director change · Regulation FD disclosure
- Item 5.02 Departure or appointment of directors or officers
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading d914907d8k.htm…